Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015.
about
The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.Temporal Trends in the Prevalence and Incidence of Diagnosed ADHD in Children and Young Adults between 1999 and 2012 in Canada: A Data Linkage Study.Psychotropic medication use in Australia, 2007 to 2015: Changes in annual incidence, prevalence and treatment exposure.Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity.The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder.Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium.Placental Complications Associated With Psychostimulant Use in Pregnancy.Chiral analysis of amphetamines in hair by liquid chromatography-tandem mass spectrometry: compliance-monitoring of attention deficit hyperactivity disorder (ADHD) patients under Elvanse® therapy and identification after controlled low-dose applicatPatient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea.Patterns and profiles of Methylphenidate use in both children and adults.Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis
P2860
Q33898415-923650D8-7AF6-4006-A531-3082DADCC824Q36406035-F74665FB-8D21-4C99-88FD-D57F2BFC9B0DQ38652321-EF115C6C-5348-4D8E-B53F-7FAE3A5043C3Q38663434-EDB7A602-04A7-4E89-8267-AE6AB8D729B0Q39433708-8D95D5C9-C469-4ED5-A637-92B115A039E4Q47313347-374236EB-54A2-4086-95B8-E538C1E3BD61Q47616895-7804D3DE-D0FE-44F2-8C9D-740DD9349D62Q48236119-99A20D2F-3A31-46DD-B8DE-3947E86D0B3DQ51345051-A081508C-C0B7-41FD-A1E1-DFCB5566DBCFQ51411756-83FB1C07-CC54-42BD-A150-E1D48F258954Q58777537-C24C9131-EAA8-4B66-92D8-B9626995DCF5
P2860
Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Prescribing trends of attentio ...... in UK primary care, 1995-2015.
@en
type
label
Prescribing trends of attentio ...... in UK primary care, 1995-2015.
@en
prefLabel
Prescribing trends of attentio ...... in UK primary care, 1995-2015.
@en
P2093
P2860
P356
P1476
Prescribing trends of attentio ...... in UK primary care, 1995-2015.
@en
P2093
Christel Renoux
Emma Fergusson
Samy Suissa
Sophie Dell'Aniello
P2860
P304
P356
10.1111/BCP.13000
P407
P577
2016-05-04T00:00:00Z